Literature DB >> 19584968

Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.

Michael McGillion1, Philippe L L'Allier, Heather Arthur, Judy Watt-Watson, Nelson Svorkdal, Tammy Cosman, Paul Taenzer, Anil Nigam, Louise Malysh.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19584968      PMCID： PMC2723022          DOI： 10.1016/s0828-282x(09)70501-x

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  19 in total

1.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

2.  Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris.

Authors:  Udho Thadani
Journal:  Coron Artery Dis       Date:  2004-05       Impact factor: 1.439

3.  Learning by heart: a focused group study to determine the self-management learning needs of chronic stable angina patients.

Authors:  Michael H McGillion; Judith H Watt-Watson; Julie Kim; Anthony Graham
Journal:  Can J Cardiovasc Nurs       Date:  2004

4.  Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study.

Authors:  O Ekre; T Eliasson; H Norrsell; P Währborg; C Mannheimer
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

Review 5.  Pain mechanisms: a new theory.

Authors:  R Melzack; P D Wall
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

6.  Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population.

Authors:  B Brorsson; S J Bernstein; R H Brook; L Werkö
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

7.  The current cost of angina pectoris to the National Health Service in the UK.

Authors:  S Stewart; N F Murphy; N Murphy; A Walker; A McGuire; J J V McMurray
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

8.  Burden of cardiovascular disease in Canada.

Authors:  Douglas G Manuel; Mark Leung; Kathy Nguyen; Peter Tanuseputro; Helen Johansen
Journal:  Can J Cardiol       Date:  2003-08       Impact factor: 5.223

Review 9.  Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.

Authors:  Nelson Svorkdal
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2004-03

10.  Cost of illness for chronic stable angina patients enrolled in a self-management education trial.

Authors:  Michael H McGillion; Ruth Croxford; Judy Watt-Watson; Sandra Lefort; Bonnie Stevens; Peter Coyte
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223
View more
  9 in total

1.  The need for a Canadian pain strategy.

Authors:  Mary E Lynch
Journal:  Pain Res Manag       Date:  2011 Mar-Apr       Impact factor: 3.037

2.  What Is the Latest in Pain Mechanisms and Management?

Authors:  Mary E Lynch
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

Review 3.  Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Authors:  Mary E Lynch; Fiona Campbell
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

4.  Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris.

Authors:  Andrew Cassar; Megha Prasad; Martin Rodriguez-Porcel; Guy S Reeder; Darshak Karia; Anthony N DeMaria; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

Review 5.  Effectiveness of percutaneous laser revascularization therapy for refractory angina.

Authors:  Michael McGillion; Allison Cook; J Charles Victor; Sandra Carroll; Julie Weston; Kevin Teoh; Heather M Arthur
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

6.  VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells.

Authors:  Clarissa G Rodrigues; Rodrigo D M Plentz; Thiago Dipp; Felipe B Salles; Imarilde I Giusti; Roberto T Sant'Anna; Bruna Eibel; Ivo A Nesralla; Melissa Markoski; Nance N Beyer; Renato A K Kalil
Journal:  Arq Bras Cardiol       Date:  2013-07-09       Impact factor: 2.000

7.  Development of a patient decision aid for people with refractory angina: protocol for a three-phase pilot study.

Authors:  Michael Hugh McGillion; Sandra Lee Carroll; Kelly Metcalfe; Heather Mary Arthur; Joseph Charles Victor; Robert McKelvie; Etienne Marc Jolicoeur; Marie-Gabrielle Lessard; James Stone; Nelson Svorkdal; John George Hanlon; Ada Andrade; Joel Niznick; Louise Malysh; William McDonald; Bonnie Stevens; Peter Coyte; Dawn Stacey
Journal:  Health Qual Life Outcomes       Date:  2014-06-11       Impact factor: 3.186

8.  Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.

Authors:  Meghan J Elliott; Sarah L Booth; Wilma M Hopman; Rachel M Holden
Journal:  Can J Kidney Health Dis       Date:  2014-06-24

Review 9.  Ranolazine: A Contemporary Review.

Authors:  Erin Rayner-Hartley; Tara Sedlak
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.